Related Experiment Video
Updated: Sep 9, 2025

Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
Management of posttraumatic refractory paroxysmal sympathetic hyperactivity with bromocriptine: a case report
Min-Seok Woo1, Seong-Hyun Park1, Jeong-Hyun Hwang1
1Department of Neurosurgery, Kyungpook National University School of Medicine, Daegu, Korea.
This case report details a successful bromocriptine treatment for refractory paroxysmal sympathetic hyperactivity (PSH) after traumatic brain injury. Bromocriptine effectively managed severe PSH symptoms, offering a new therapeutic option.
Area of Science:
- Neuroscience
- Neurology
- Trauma Care
Background:
- Traumatic brain injury (TBI) can lead to complex neurological complications.
- Paroxysmal sympathetic hyperactivity (PSH) is a rare but severe condition characterized by autonomic dysregulation.
- Refractory PSH poses significant management challenges, often resistant to standard treatments.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Psychosis: Goals of Pharmacotherapy
Mania and Antimanic Drugs: Overview
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
COPD: Management Using Bronchodilators and Corticosteroids
REM Sleep Behavior Disorder
RBD is significantly associated with...

